Diovan 320 mg comprimidos recubiertos con pelicula

Label: information for the user

Diován 320film-coated tablets

valsartán

Read this label carefully before starting to take this medicine,because it contains important information for you.

• Keep this label, as you may need to read it again..
• If you have any questions, consult your doctor or pharmacist.
• This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms as you, as it may harm them.
• If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this label. See section 4.

Diován contains the active ingredient: valsartán and belongs to a class of medications known as angiotensin II receptor antagonists, which help control high blood pressure. Angiotensin II is a substance in the body that causes blood vessels to constrict, resulting in increased blood pressure. Diován acts by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure decreases.

Diován 320mg film-coated tabletscan be used

• to treat high blood pressure in adults and in children and adolescents from6 toless than 18years of age.High blood pressure increases the workload of the heart and arteries. If left untreated, it can damage blood vessels in the brain, heart, and kidneys, and may cause a stroke, heart failure, or kidney failure. High blood pressure increases the risk of heart attacks. Reducing blood pressure to normal values reduces the risk of developing these disorders.

Do not take Diován:

• if you areallergic(hypersensitive) to valsartán or any of the other components of this medication (listed in section 6).
• if you havesevere liver disease.
• if you arepregnantover 3 months(it is better to avoid Diován during the first months of pregnancy – see section Pregnancy).
• if you have diabetes or kidney insufficiency and are being treated with a medication to reduce blood pressure that contains aliskirén.

If any of the above situations affect you, inform your doctor and do not takeDiován.

Warnings and precautions:

Consult your doctor

• if you have liver disease.
• if you have severe kidney disease or if you are undergoing dialysis.
• if you have a narrowing of the renal artery.
• if you have recently undergone a kidney transplant (received a new kidney).
• if you have severe heart disease other than heart failure or myocardial infarction.
• if you have experienced swelling of the tongue and face caused by an allergic reaction called angioedema when taking other medications (including ACEIs), inform your doctor. If you have these symptoms when taking Diován, stop taking Diován immediately and never take it again. See also section 4 “Possible side effects”.
• if you are using medications that increase the amount of potassium in the blood. Among them are potassium supplements or salt substitutes that contain potassium, potassium-sparing medications, and heparin. You may need to regularly control the amount of potassium in the blood.
• if you have aldosteronism, a disease in which the adrenal glands produce too much aldosterone hormone. In this case, it is not recommended to take Diován.
• if you have lost a lot of fluid (dehydration) due to diarrhea, vomiting, or high doses of diuretics (medications to increase urine elimination).
• if you are taking any of the following medications used to treat high blood pressure:
• • a converting enzyme inhibitor (ACEI) (for example enalapril, lisinopril, etc.,)
  • aliskirén

Your doctor may monitor your renal function, blood pressure, and electrolyte levels (such as potassium) in the blood at regular intervals.

See also the information under the heading “Do not take Diován”.

You must inform your doctor if you think you are (or could be) pregnant. Diován is not recommended at the beginning of pregnancy, and it should not be taken if you are pregnant over3months, as it could cause serious harm to your baby if you use it during this period (see the Pregnancy section).

Use of Diován with other medications

Inform your doctor or pharmacist if you are using, have used recentlyor could have to useany other medication.

The effect of treatment with Diován may be altered if taken with certain medications. Your doctor may need to modify your dose and/or take other precautions or, in some cases, stop treatment with one of the medications. This applies to both prescription and non-prescription medications, especially:

• other medications that lower blood pressure,especiallydiuretics(medications to increase urine elimination), ACEIs(such as enalapril, lisinopril, etc.,) or aliskirén(see also the information under the headings“Do not take Diován” and “Warnings and precautions”).
• medications that increase the amount of potassiumin the blood. Among them are potassium supplements or salt substitutes that contain potassium, potassium-sparing medications, and heparin.
• certain medications for paincalled nonsteroidal anti-inflammatory drugs (NSAIDs).
• some antibiotics (of the rifampicin group), a medication used to protect against rejection in a transplant (ciclosporina) or an antiretroviral medication used to treat HIV/AIDS (ritonavir). These medications may increase the effect of Diován.
• lithium,a medication used to treat certain types of psychiatric disorders.

Pregnancy and lactation

• You must inform your doctor if you are pregnant(or if you suspect that you might be).Your doctor will usually recommend that you stop taking Diován before becoming pregnant or as soon as you know you are pregnant and recommend that you take another medication instead of Diován. Diován is not recommended at the beginning of pregnancy, and it should not be administered after the third month of pregnancy as it may cause serious harm to your baby when administered from that point onwards.

• Inform your doctor if you are breastfeeding or are about to start. Diován is not recommended during breastfeeding, and your doctor will choose another treatment for you if you want to breastfeed, especially if your baby is newborn or premature.

Driving and operating machinery

Before driving a vehicle, using tools, or operating machinery, or performing other activities that require concentration, make sure you know how Diován affects you. Like many other medications used to treat high blood pressure, Diován may cause dizziness and affect concentration.

To get the best results and reduce the risk of adverse effects, take this medication exactly as your doctor tells you to.In case of doubt, ask yourdoctor or pharmacist. People with high blood pressure often do not notice any signs of the disease; many feel normal. This makes it very important to attend your appointments with the doctor, even if you feel well.

Adult patients with high blood pressure:The recommended dose is 80mg per day. In some cases, your doctor may prescribe higher doses (e.g. 160mg or 320mg). You may also combine Diován with another medication (e.g. a diuretic).

Use in children and adolescents from6 to less than 18years of age with high blood pressure:

In patients weighing less than 35kg, the recommended starting dose for Diován tablets is 40mg once a day.

In patients weighing 35kg or more, the recommended starting dose for Diován tablets is 80mg once a day.

In some cases, your doctor may prescribe higher doses (the dose may be increased to 160mg and up to a maximum of 320mg).

In children who have difficulty swallowing the tablets, administration of Diován oral solution is recommended.

You can take Diován with or without food. Swallow Diován with a glass of water.

Take Diován approximately at the same time every day.

If you take more Diován than you should

If you experience severe dizziness and/or fainting, contact your doctor immediately and lie down. If you have accidentally taken too many tablets, contact your doctor, pharmacist, or hospital.You can also call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount taken.

If you forget to take Diován

If you forget to take a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose.

Do not take a double dose to make up for the missed doses.

If you interrupt treatment withDiován

If you stop taking Diován, your condition may worsen. Do not stop taking the medication unless your doctor tells you to.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

Some side effects can be serious and may require immediate medical attention:

You may experience symptoms of angioedema (a specific allergic reaction), such as

• swelling in the face, lips, tongue, or throat
• difficulty breathing or swallowing
• hives, itching

If you experience any of these symptoms, stop taking Diován and contact your doctor immediately (see also section 2 “Warnings and precautions”).

Other side effects include:

Frequent(may affect up to 1 in 10 people):

• dizziness
• low blood pressure with or without symptoms such as dizziness and fainting when standing up
• reduction in kidney function (signs of renal deterioration)

Rare(may affect up to 1 in 100 people):

• angioedema (see section “Some symptoms require immediate medical attention”)
• sudden loss of consciousness (syncope)
• sensation of spinning (vertigo)
• marked reduction in kidney function (signs of acute renal insufficiency)
• muscle spasms, abnormal heart rhythm (signs of hyperkalemia)
• shortness of breath, difficulty breathing while lying down, swelling of the feet or legs (signs of heart failure)
• headache
• cough
• abdominal pain
• nausea
• diarrhea
• fatigue
• weakness

Unknown frequency(cannot be estimated from available data):

• blistering on the skin (sign of dermatitis herpetiformis)
• may occur allergic reactions with skin rash, itching, and hives; symptoms of serum sickness, such as fever, swelling, and joint pain, muscle pain, swelling of lymph nodes, and/or symptoms similar to the flu
• red purpuric patches, fever, itching (signs of inflammation of blood vessels, also known as vasculitis)
• more frequent bleeding or bruising than usual (signs of thrombocytopenia)
• muscle pain (myalgia)
• fever, sore throat, or mouth ulcers due to infections (symptoms of low white blood cell count, also known as neutropenia)
• reduction in hemoglobin level and reduction in percentage of red blood cells in the blood (which, in severe cases, may cause anemia)
• increase in potassium level in the blood (which, in severe cases, may cause muscle spasms and abnormal heart rhythm)
• elevation of liver function values (which may indicate liver damage), including an increase in bilirubin level in the blood (which, in severe cases, may cause the skin and eyes to turn yellow)
• increase in urea nitrogen level in the blood and increase in serum creatinine level (which may indicate renal anomalies)
• low sodium level in the blood (which, in severe cases, may cause fatigue, confusion, muscle fasciculations, and/or seizures)

The frequency of some side effects may vary depending on your condition. For example, certain side effects such as dizziness and reduction in kidney function were observed less frequently in adult patients treated for high blood pressure than in adult patients treated for heart failure or after a recent heart attack.

Side effects in children and adolescents are similar to those observed in adults.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use (www.notificaRAM.es). By reporting side effects, you can contribute to providing more information on the safety of this medicine.

• Keep out of sight and reach of children.
• Do not use this medication after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
• Do not store at a temperature above 86°F (30°C). Store in the original packaging to protect it from moisture.
• Do not use this medication if you observe that the packaging is damaged or shows signs of handling.
• Medicines should not be disposed of through drains or in the trash.Deposit the packaging and medicines that you no longer need at theSIGREcollection pointof the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. By doing so, you will help protect the environment.

Composition ofDiován

• The active ingredient is valsartán. Each film-coated tablet contains 320 mg of valsartán.
• The other components are microcrystalline cellulose, crospovidone type A, anhydrous colloidal silica, magnesium stearate. The tablet coating contains hypromellose, titanium dioxide (E 171), macrogol 8000, red iron oxide (E 172), yellow iron oxide (E 172), black iron oxide (E 172).

Appearance of the product and contents of the package

The film-coated tablets of Diován 320 mg are dark greyish violet, oval, with beveled edges and a notch on one side. They have the mark “DC” on one side of the notch and “DC” on the other side of the notch and “NVR” on the opposite side of the tablet.The notch is only for splitting and facilitating swallowing, but not for dividing into equal doses.

The tablets are presented in blister packs with 7, 14, 28, 30, 56, 90 or 98 tablets and in calendar blister packs with 14, 28, 56, 98 and 280 tablets. Blister packs with 56x1, 98x1 or 280x1 tablets are also available.

Only some package sizes may be marketed.

Marketing Authorization Holder

Novartis Farmacéutica S.A.
Gran Vía de les Corts Catalanes, 764
08013 Barcelona

Tel: 93-306 42 00

Responsible for manufacturing

Novartis Farmacéutica, S.A.

Gran Vía de les Corts Catalanes, 764

08013 Barcelona

Spain

Novartis Farma S.p.A.

Viale Luigi Sturzo 43

20154 Milano (MI)

Italy

Novartis Sverige AB

Torshamnsgatan 48

164 40 Kista

Sweden

Novartis Farma – Productos Farmacêuticos, S.A.

Avenida Professor Doutor Cavaco Silva, n.° 10E (Taguspark, Porto Salvo).

Oeiras Parish. 2740 255.

Portugal

Novartis Pharma S.A.S.

8-10 rue Henri Sainte-Claire Deville

92500 Rueil-Malmaison

France

Novartis Pharma B.V.

Haaksbergweg 16

1101 BX Amsterdam

Netherlands

Novartis Pharma GmbH

Jakov-Lind-Straße 5, Top 3.05

1020 Vienna

Austria

Novartis Farma S.p.A.

Via Provinciale, Schito131

80058 Torre Annunziata (NA)

Italy

Novartis Pharma GmbH

Sophie-Germain-Strasse 10

90443 Nuremberg

Germany

Further information about this medicinal product can be obtained by contacting the marketing authorization holder.

This medicinal product is authorized in themember states of the European Economic Area withthe following names:

Last review date of this leaflet:06/2020

Further detailed and updated information about this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) htpp://www.aemps.gob.es/